CDFT Stock | News | Quote | Stock Forum | Monday, November 25,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$CDFT Citadel EFT, Inc. CDFT Company Overview 

Citadel EFT, Inc. CDFT Current Price and Quotes
Last Price 10.50
Previous Close 10.50 Open N/A
Daily Range N/A - N/A 52wk Range 10.50 - 1.00
Volume 0 Dividend N/A
Average Vol (3m) 576 Yield N/A

CDFT Stock Message Board http://investorshangout.com/search?q=CDFT&...mp;yt1=Go!

Last Updated: Monday, November 25, 2013 01:59:51 AM

Citadel EFT, Inc. CDFT
Company Information

825 College Blvd.
Suite 102
Oceanside, CA 92057

Website: http://www.citadelbankcard.com
Phone: 714-423-0701
Email: investors@citadelbankcard.com

Citadel EFT, Inc. CDFT
Citadel EFT, Inc. CDFT
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001473971
Fiscal Year End 9/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 7389 - Business services, misc
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Gary DeRoos CEO
Company Directors

Not Available
Service Providers

Auditor/Accountant
Lynda R. Keeton CPA, LLC
375 N. Stephanie Street
Building 2 Suite 211
Henderson, NV, 89014
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Citadel EFT, Inc. CDFT
CDFT Security Details

Share Structure

Market Value1 $282,606,492 a/o Nov 22, 2013
Shares Outstanding 26,914,904 a/o Aug 14, 2013
Float Not Available
Authorized Shares Not Available
Par Value  Not Available
Shareholders

Shareholders of Record 30 a/o Jan 16, 2013
Security Notes

Capital Change=shs decreased by 1 for 12000 split. Ex-date=06/14/2013.
Short Selling Data

Short Interest 31 (100%)
Oct 31, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Quicksilver Stock Transfer, LLC

Citadel EFT, Inc. CDFT Financials
Period Ending Sep 30, 2012 Sep 30, 2011 Sep 30, 2010 Sep 30, 2009
Total Revenue 493 460 337 262
Cost of Revenue - - - -
Gross Profit 493 460 337 262
Operating Expenses

Research and Development - - - -
Sales, General and Admin. - - 271 210
Non-Recurring Items - - - -
Other - - - -
Operating Income (1,894) (24,454) 66 52
Income From Continuing Operations

Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax (1,894) (24,454) 66 52
Interest Expense - - - -
Earnings Before Tax (1,894) (24,454) 66 52
Income Tax - 3 58 4
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,894) (24,457) 7 48
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,894) (24,457) 7 48
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,894) (24,457) 7 48

Citadel EFT, Inc. CDFT Recent News

Sep 17, 2013 Citadel EFT, Inc. (CDFT) Announces the Addition of Two High Volume Merchants


CDFT Citadel EFT, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CDFT&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CDFT/quote
Stock Chart http://www.otcmarkets.com/stock/CDFT/chart
Company Info http://www.otcmarkets.com/stock/CDFT/company-info
Recent News http://www.otcmarkets.com/stock/CDFT/news
Financials http://www.otcmarkets.com/stock/CDFT/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CDFT/filings
Short Sales http://www.otcmarkets.com/stock/CDFT/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CDFT/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CDFT/research
Summary http://finance.yahoo.com/q?s=CDFT
Historical Prices http://finance.yahoo.com/q/hp?s=CDFT+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CDFT
Basic Chart http://finance.yahoo.com/q/bc?s=CDFT+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CDFT+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CDFT+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CDFT+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CDFT+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CDFT+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CDFT+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CDFT+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CDFT+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CDFT+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CDFT
Balance Sheet http://finance.yahoo.com/q/bs?s=CDFT
Cash Flow http://finance.yahoo.com/q/cf?s=CDFT+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CDFT
Market Watch http://www.marketwatch.com/investing/stock/CDFT
Bloomberg http://www.bloomberg.com/quote/CDFT:US
Morningstar http://quotes.morningstar.com/stock/s?t=CDFT
Bussinessweek http://investing.businessweek.com/research/st...icker=CDFT
Barchart http://www.barchart.com/quotes/stocks/CDFT
OTC Short Report http://otcshortreport.com/index.php?index=CDFT
Investopedia http://www.investopedia.com/markets/stocks/CDFT/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Palisade Bio Launches PALI-2108 Study to Combat Crohn’s Disease

Updated Category News Views 142

Exciting Developments in Crohn’s Disease Treatment Today marks a pivotal point as Palisade Bio, Inc. (NASDAQ: PALI), a dynamic clinical-stage biopharmaceutical firm, undertakes a groundbreaking step in medical research by announcing the commencement of patient dosing in their Phase 1b clinical trial. This study is focused on PALI-2108, a novel therapeutic designed...

Continue Reading
Discover How Your $100 Investment in TD Synnex Has Grown

Updated Category News Views 126

Understanding the Growth of Your Investment in TD Synnex Investing in stocks can often feel like navigating a complex maze, especially when evaluating potential growth over time. One standout in the tech industry is TD Synnex (NASDAQ: SNX), a company that has consistently outperformed benchmark indices. Over the past five years, TD Synnex has achieved an annualized return...

Continue Reading
Castor Maritime Inc. Completes Successful Sale and Leaseback

Updated Category News Views 170

Castor Maritime Inc. Completes Successful Sale and Leaseback Castor Maritime Inc. (NASDAQ: CTRM), a versatile player in the global shipping and energy sector, recently announced an exciting development. The company successfully concluded a significant sale and leaseback transaction for its vessel, the M/V Magic Thunder, an impressive Kamsarmax bulk carrier that was built...

Continue Reading
Yamaha's Partnership with Locally Enhances Dealer Collaboration

Updated Category News Views 153

Yamaha Expands Dealer Network with Innovative Omnichannel Solutions Yamaha, a renowned global leader in musical instruments and audio solutions, has recently announced a strategic partnership with Locally. This collaboration aims to elevate the shopping experience for consumers and to strengthen relationships with local retailers. This initiative is particularly...

Continue Reading
POET Technologies Celebrates AI Award Win at Global Tech Awards

Updated Category News Views 73

POET Technologies' Landmark Achievement in Artificial Intelligence POET Technologies Inc. (TSX Venture: PTK; NASDAQ: POET), known for its groundbreaking work with the POET Optical Interposer™, has recently been honored with the title of "Best in Artificial Intelligence" at the Global Tech Awards 2024. This prestigious recognition was announced following the awards...

Continue Reading